Premium
Combined Chemotherapy in the Management of Metastatic Bladder Cancer
Author(s) -
GIRALT E GARCIA,
AUVERT J.,
LACHAND A. T.,
BOTTO H.,
ABBOU C.,
HANNOUN M.,
POUILLART P.,
PALANGIE T.,
JOUVE M.,
MORlN Ph.
Publication year - 1981
Publication title -
british journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 0007-1331
DOI - 10.1111/j.1464-410x.1981.tb03187.x
Subject(s) - medicine , mitomycin c , bladder cancer , fluorouracil , chemotherapy , oncology , urology , cancer , surgery
Summary —In a non‐randomised study, 30 patients with metastatic bladder cancer were treated with a combination of Adriamycin, VM 26, 5‐fluorouracil (5‐FU) and mitomycin C. A significant response was observed in 1 8 patients and the median survival was 300 days.